Chintalacharuvu K R, Tavill A S, Louis L N, Vaerman J P, Lamm M E, Kaetzel C S
Institute of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4943.
Hepatology. 1994 Jan;19(1):162-73.
The polymeric immunoglobulin receptor on rat hepatocytes binds dimeric IgA on the sinusoidal surface and mediates its transport to the canaliculus, where the complex of dimeric IgA and secretory component, the cleaved extracellular domain of polymeric immunoglobulin receptor, is secreted into bile. This process is unique in that disulfide bonds are formed between dimeric IgA and polymeric immunoglobulin receptor during transcytosis, permanently preventing their dissociation. Here we present three lines of evidence that disulfide bonding between dimeric IgA and polymeric immunoglobulin receptor occurs predominantly in a late transcytotic compartment and that hepatic transcytosis can proceed in the absence of disulfide bond formation. First, throughout the course of transcytosis the percentage of intracellular dimeric IgA disulfide bonded to polymeric immunoglobulin receptor is less than half that in bile, suggesting that disulfide bond formation is a late event in transcytosis. Second, dimeric IgA that recycles from early endocytotic compartments into the circulation is mostly noncovalently bound to secretory component. Finally, the rate of transcytosis of dimeric IgA and its appearance in bile are not affected when disulfide bond formation with polymeric immunoglobulin receptor is inhibited by blocking of free thiol groups on dimeric IgA with iodoacetamide. These results are consistent with other findings in the literature and indicate that the main physiological role of disulfide bond formation between dimeric IgA and polymeric immunoglobulin receptor is not to facilitate transcytosis but, rather, to stabilize the dimeric IgA-secretory component complex after its release into external secretions such as bile and intestinal secretions.
大鼠肝细胞上的多聚免疫球蛋白受体在肝血窦表面结合二聚体IgA,并介导其向胆小管转运,在胆小管处,二聚体IgA与分泌成分(多聚免疫球蛋白受体的细胞外裂解结构域)的复合物被分泌到胆汁中。这一过程的独特之处在于,在转胞吞作用期间二聚体IgA与多聚免疫球蛋白受体之间形成二硫键,从而永久性地阻止它们解离。在此,我们提供三条证据表明,二聚体IgA与多聚免疫球蛋白受体之间的二硫键形成主要发生在转胞吞作用后期的区室中,并且在没有二硫键形成的情况下肝脏转胞吞作用也可以进行。第一,在整个转胞吞过程中,与多聚免疫球蛋白受体形成二硫键的细胞内二聚体IgA的百分比不到胆汁中的一半,这表明二硫键形成是转胞吞作用后期的事件。第二,从早期内吞区室循环回来的二聚体IgA大多与分泌成分非共价结合。最后,当用碘乙酰胺封闭二聚体IgA上的游离巯基从而抑制其与多聚免疫球蛋白受体形成二硫键时,二聚体IgA的转胞吞速率及其在胆汁中的出现不受影响。这些结果与文献中的其他发现一致,表明二聚体IgA与多聚免疫球蛋白受体之间形成二硫键的主要生理作用不是促进转胞吞作用,而是在二聚体IgA-分泌成分复合物释放到胆汁和肠道分泌物等外分泌液后使其稳定。